PolicyBrief
S. 1535
119th CongressApr 30th 2025
Rural Patient Monitoring (RPM) Access Act
IN COMMITTEE

This bill establishes a minimum payment floor for rural remote patient monitoring services and sets new quality standards for Medicare providers offering remote monitoring.

Marsha Blackburn
R

Marsha Blackburn

Senator

TN

LEGISLATION

Rural Monitoring Bill Boosts Medicare Payments and Demands New Quality Standards Starting 2026

The Rural Patient Monitoring (RPM) Access Act is designed to tackle a big problem: folks in rural areas often have poor access to healthcare. This bill focuses on making sure Medicare patients, especially those managing chronic conditions, can reliably use remote physiologic monitoring (RPM)—which is basically having your doctor track your vital signs and health data from afar.

The Money Fix: No More Nickel-and-Diming Rural Care

Starting January 1, 2026, the bill changes how Medicare calculates payment for these RPM services. Right now, costs for things like staff time and malpractice insurance (known as practice expenses and malpractice indices) can be calculated lower in rural states, even though the actual cost of running the monitoring technology doesn't really change based on geography. This bill establishes a floor: if those calculation indices fall below 1.00, they get bumped up to exactly 1.00. This is a big deal for rural providers because it ensures they get a more realistic reimbursement for their operational costs, making it financially viable to offer these services. For a Medicare patient in a remote area, this could mean the difference between having their blood pressure or glucose monitored daily from home versus having to drive an hour to a clinic.

Crucially, Section 3 specifies that this payment adjustment is not budget-neutral. Think of it this way: usually, if Medicare increases payments in one area, they have to cut them somewhere else to balance the books. Not here. This increase is an added cost to the Medicare program. While this is great news for providers and patient access, it means the overall cost to the Medicare Trust Fund is going up, which is something taxpayers and future beneficiaries should keep an eye on.

New Rules for High-Tech Health

Section 4 moves beyond just the money and sets new quality standards for providers offering RPM to Medicare beneficiaries. If a clinic is monitoring your vitals remotely, they now have to meet specific requirements to ensure you’re actually getting good care. They must be set up to quickly react to any "weird data spikes or anomalies"—whether they handle the clinical support themselves or contract it out. They also need to ensure all your monitoring data and treatment notes can be sent directly to your supervising doctor’s electronic health record (EHR) for seamless care coordination.

This is a win for patients because it formalizes the quality of care. It means the monitoring isn't just data collection; it’s supposed to be actionable. However, the bill gives the Secretary of Health and Human Services (HHS) a lot of power to define what those "weird data spikes" are and what the exact reporting requirements look like. This level of regulatory discretion could be a headache for providers trying to comply, especially since the bill allows the Secretary to create exceptions for small medical practices. If those exceptions aren't handled well, it could create uneven playing fields or still leave small practices struggling with the high bar of data integration.

What the Government Needs to Know

Finally, the bill mandates that the HHS Secretary must send a detailed report to Congress two years after the law is enacted. This report needs to analyze the financial impact of RPM, specifically looking at how much money Medicare saves because patients using remote monitoring have fewer hospital days and stick to their medication better. It also requires an analysis of the actual costs practices incur to provide the service, like technology platform maintenance and connectivity. This required reporting is a good check and balance, forcing the government to track if the cost increases in Section 3 are actually paying off in better patient outcomes and reduced long-term spending.